Keywords
Last Name
Institution

KEVIN W. GAREY

TitleProfessor
InstitutionUniversity of Houston College of Pharmacy
DepartmentClinical Sciences & Administration
AddressTexas Medical Center Campus, Rm 322
1441 Moursund
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, Devaraj S, Tessier ME, von Rosenvinge EC, Kelly CP, Pasetti MF, Feng H. Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity. Clin Vaccine Immunol. 2017 Jun 07. PMID: 28592627.
      View in: PubMed
    2. Endres B, Bassères E, Rashid T, Chang L, Alam MJ, Garey KW. A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment. J Vis Exp. 2017 May 25; (123). PMID: 28570548.
      View in: PubMed
    3. Shea KM, Hobbs AL, Jaso TC, Bissett JD, Cruz CM, Douglass ET, Garey KW. Effect of a Healthcare-system Respiratory Fluoroquinolone Restriction Program to Alter Utilization and Impact Rates of C. difficile Infection. Antimicrob Agents Chemother. 2017 Mar 27. PMID: 28348151.
      View in: PubMed
    4. Endres BT, Bassères E, Alam MJ, Garey KW. Cadazolid for the treatment of Clostridium difficile. Expert Opin Investig Drugs. 2017 Mar 13. PMID: 28286992.
      View in: PubMed
    5. Alam MJ, Walk ST, Endres BT, Basseres E, Khaleduzzaman M, Amadio J, Musick WL, Christensen JL, Kuo J, Atmar RL, Garey KW. Community Environmental Contamination of Toxigenic Clostridium difficile. Open Forum Infect Dis. 2017; 4(1):ofx018. PMID: 28480289.
      View in: PubMed
    6. Bassères E, Endres BT, Dotson KM, Alam MJ, Garey KW. Novel antibiotics in development to treat Clostridium difficile infection. Curr Opin Gastroenterol. 2017 Jan; 33(1):1-7. PMID: 28134686.
      View in: PubMed
    7. Rashid T, Vonville H, Hasan I, Garey KW. Mechanisms for floor surfaces or environmental ground contamination to cause human infection: a systematic review. Epidemiol Infect. 2017 Jan; 145(2):347-357. PMID: 27780492.
      View in: PubMed
    8. Rashid T, VonVille HM, Hasan I, Garey KW. Shoe soles as a potential vector for pathogen transmission: a systematic review. J Appl Microbiol. 2016 Nov; 121(5):1223-1231. PMID: 27495010.
      View in: PubMed
    9. Garey KW, Aitken SL, Gschwind L, Goddu S, Xie Y, Duff C, Barbut F, Shah DN, DuPont HL. Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire. J Clin Gastroenterol. 2016 Sep; 50(8):631-7. PMID: 26796081; PMCID: PMC4978607.
    10. Shah DN, Chan FS, Kachru N, Garcia KP, Balcer HE, Dyer AP, Emanuel JE, Jordan MD, Lusardi KT, Naymick G, Polisetty RS, Sieman L, Tyler AM, Johnson ML, Garey KW. A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus. 2016; 5(1):1224. PMID: 27536508; PMCID: PMC4970984.
    11. Gorbach C, Blanton L, Lukawski B, Varkey AC, Pitman P, Garey KW. Benchmarking and medication error rates. Am J Health Syst Pharm. 2016 Jun 1; 73(11):746. PMID: 27208057.
      View in: PubMed
    12. Vickers RJ, Tillotson G, Goldstein EJ, Citron DM, Garey KW, Wilcox MH. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug; 48(2):137-43. PMID: 27283730.
      View in: PubMed
    13. Endres BT, Bassères E, Khaleduzzaman M, Alam MJ, Chesnel L, Garey KW. Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes. Antimicrob Agents Chemother. 2016 Jun; 60(6):3519-23. PMID: 27021314; PMCID: PMC4879405 [Available on 12/01/16].
    14. Endres BT, Bassères E, Memariani A, Chang L, Alam MJ, Vickers RJ, Kakadiaris IA, Garey KW. A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile. Anaerobe. 2016 Aug; 40:10-4. PMID: 27108094.
      View in: PubMed
    15. Shah DN, Aitken SL, Barragan LF, Bozorgui S, Goddu S, Navarro ME, Xie Y, DuPont HL, Garey KW. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J Hosp Infect. 2016 Jul; 93(3):286-9. PMID: 27209056.
      View in: PubMed
    16. Thabit AK, Alam MJ, Khaleduzzaman M, Garey KW, Nicolau DP. A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin. Ann Clin Microbiol Antimicrob. 2016; 15:22. PMID: 27071986; PMCID: PMC4830079.
    17. Bassères E, Endres BT, Khaleduzzaman M, Miraftabi F, Alam MJ, Vickers RJ, Garey KW. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother. 2016 May; 71(5):1245-51. PMID: 26895772; PMCID: PMC4830417.
    18. Philip A, Desai A, Nguyen PA, Birney P, Colavecchia A, Karralli R, Smith L, Lorimer D, Burgess G, Munch K, Daniel N, Lionetti J, Garey KW. Evaluating pharmacy leader development through the seven action logics. Am J Health Syst Pharm. 2016 Jan 15; 73(2):82-5. PMID: 26721538.
      View in: PubMed
    19. Sayles C, Hickerson SC, Bhat RR, Hall J, Garey KW, Trivedi MV. Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review. Nutr Clin Pract. 2016 Apr; 31(2):171-9. PMID: 26507188.
      View in: PubMed
    20. Gorbach C, Blanton L, Lukawski BA, Varkey AC, Pitman EP, Garey KW. Frequency of and risk factors for medication errors by pharmacists during order verification in a tertiary care medical center. Am J Health Syst Pharm. 2015 Sep 1; 72(17):1471-4. PMID: 26294240.
      View in: PubMed
    21. Aitken SL, Alam MJ, Khaleduzzuman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent. Infect Control Hosp Epidemiol. 2015 Nov; 36(11):1318-23. PMID: 26288985.
      View in: PubMed
    22. Pham VP, Luce AM, Ruppelt SC, Wei W, Aitken SL, Musick WL, Roux RK, Garey KW. Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole. Antimicrob Agents Chemother. 2015 Oct; 59(10):6113-6. PMID: 26195522.
      View in: PubMed
    23. Blee J, Roux RK, Gautreaux S, Sherer JT, Garey KW. Dispensing inhalers to patients with chronic obstructive pulmonary disease on hospital discharge: Effects on prescription filling and readmission. Am J Health Syst Pharm. 2015 Jul 15; 72(14):1204-8. PMID: 26150570.
      View in: PubMed
    24. Beyda ND, Liao G, Endres BT, Lewis RE, Garey KW. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates. Antimicrob Agents Chemother. 2015 Sep; 59(9):5405-12. PMID: 26100700.
      View in: PubMed
    25. Philip A, Gessner-Wharton M, Birney P, Blee J, Desai A, Gorbach C, Karralli R, Lorimer D, Munch K, Nweke G, Parekh S, Puebla M, Cox R, Pitman EP, Garey KW. Pharmacy Practice Model Initiative task force report: Improving participation in a survey on hospital pharmacy practices in Texas. Am J Health Syst Pharm. 2015 Jun 15; 72(12):1053-7. PMID: 26025997.
      View in: PubMed
    26. Nesher L, Hadi CM, Salazar L, Wootton SH, Garey KW, Lasco T, Luce AM, Hasbun R. Epidemiology of meningitis with a negative CSF Gram stain: under-utilization of available diagnostic tests. Epidemiol Infect. 2016 Jan; 144(1):189-97. PMID: 25989841.
      View in: PubMed
    27. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. Reply to Bauer and Goff. Clin Infect Dis. 2015 Aug 1; 61(3):487-8. PMID: 25944341.
      View in: PubMed
    28. Na X, Martin AJ, Sethi S, Kyne L, Garey KW, Flores SW, Hu M, Shah DN, Shields K, Leffler DA, Kelly CP. A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection. PLoS One. 2015; 10(4):e0123405. PMID: 25906284; PMCID: PMC4408056.
    29. Yu H, Chen K, Wu J, Yang Z, Shi L, Barlow LL, Aronoff DM, Garey KW, Savidge TC, von Rosenvinge EC, Kelly CP, Feng H. Identification of toxemia in patients with Clostridium difficile infection. PLoS One. 2015; 10(4):e0124235. PMID: 25885671; PMCID: PMC4401762.
    30. Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci. 2015 Apr; 349(4):316-20. PMID: 25607510.
      View in: PubMed
    31. Philip A, Green M, Hoffman T, Gautreaux S, Wallace D, Roux R, Garey KW. Expansion of clinical pharmacy through increased use of outpatient pharmacists for anticoagulation services. Am J Health Syst Pharm. 2015 Apr 1; 72(7):568-72. PMID: 25788511.
      View in: PubMed
    32. Kilic A, Alam MJ, Tisdel NL, Shah DN, Yapar M, Lasco TM, Garey KW. Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples. Ann Lab Med. 2015 May; 35(3):306-13. PMID: 25932438; PMCID: PMC4390698.
    33. Martinson JN, Broadaway S, Lohman E, Johnson C, Alam MJ, Khaleduzzaman M, Garey KW, Schlackman J, Young VB, Santhosh K, Rao K, Lyons RH, Walk ST. Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology. J Clin Microbiol. 2015 Apr; 53(4):1192-7. PMID: 25631804; PMCID: PMC4365229.
    34. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015 Mar 15; 60(6):892-9. PMID: 25586686.
      View in: PubMed
    35. Jacobs DM, Kuper K, Septimus E, Arafat R, Garey KW. Assessment of Antimicrobial Stewardship Activities in a Large Metropolitan Area. J Pharm Pract. 2016 Jun; 29(3):188-93. PMID: 25312262.
      View in: PubMed
    36. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015 Jan; 81(1):4-8. PMID: 25445120.
      View in: PubMed
    37. Bernhardt MB, Moffett BS, Johnson M, Tam VH, Thompson P, Garey KW. Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatr Blood Cancer. 2015 Jan; 62(1):80-4. PMID: 25263332.
      View in: PubMed
    38. Jacobs DM, Beyda ND, Asuphon O, Alam MJ, Garey KW. Host factors and clinical outcomes of Candida colonization in critically ill patients. Mycopathologia. 2015 Feb; 179(1-2):87-93. PMID: 25173925.
      View in: PubMed
    39. Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KW. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PLoS One. 2014; 9(7):e102848. PMID: 25057871; PMCID: PMC4109955.
    40. Wanat MA, Fleming ML, Fernandez JM, Garey KW. Education, training, and academic experience of newly hired, first-time pharmacy faculty members. Am J Pharm Educ. 2014 Jun 17; 78(5):92. PMID: 24954932; PMCID: PMC4064492.
    41. Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014 Sep 15; 59(6):819-25. PMID: 24879785.
      View in: PubMed
    42. Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HL. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73. PMID: 24799643.
      View in: PubMed
    43. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90. PMID: 24687545.
      View in: PubMed
    44. Alam MJ, Anu A, Walk ST, Garey KW. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe. 2014 Jun; 27:31-3. PMID: 24657158.
      View in: PubMed
    45. Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, DuPont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol. 2014 Apr; 21(4):509-17. PMID: 24477852; PMCID: PMC3993122.
    46. Wanat MA, Garey KW. A blueprint for transitioning pharmacy residents into successful clinical faculty members in colleges and schools of pharmacy. Am J Pharm Educ. 2013 Nov 12; 77(9):200. PMID: 24249862; PMCID: PMC3831411.
    47. Beyda ND, Alam MJ, Garey KW. Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis. 2013 Dec; 77(4):324-6. PMID: 24135411.
      View in: PubMed
    48. Patel TS, Crutchley RD, Tucker AM, Cottreau J, Garey KW. Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS. HIV AIDS (Auckl). 2013; 5:153-62. PMID: 23888120; PMCID: PMC3722035.
    49. Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect. 2013 Sep; 85(1):28-32. PMID: 23834988.
      View in: PubMed
    50. Huang JS, Jiang ZD, Garey KW, Lasco T, Dupont HL. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrob Agents Chemother. 2013 Jun; 57(6):2690-3. PMID: 23545528; PMCID: PMC3716149.
    51. Yeo QM, Crutchley R, Cottreau J, Tucker A, Garey KW. Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea. Drugs Today (Barc). 2013 Apr; 49(4):239-52. PMID: 23616951.
      View in: PubMed
    52. Shah DN, Bhatt NS, Welch JK, Koo HL, Garey KW. Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection. J Hosp Infect. 2013 Apr; 83(4):294-9. PMID: 23433867; PMCID: PMC3984400.
    53. Jiang ZD, Hoang LN, Lasco TM, Garey KW, Dupont HL. Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis. 2013 Apr; 56(7):1059-60. PMID: 23223589.
      View in: PubMed
    54. Haines LA, Putney KS, Varkey DA, Frost C, Pitman EP, Aparasu RR, Garey KW. Pilot of a patient-centered pharmacy practice model. Am J Health Syst Pharm. 2012 Nov 1; 69(21):1860-1. PMID: 23111668.
      View in: PubMed
    55. Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW. Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013 Feb; 68(2):438-43. PMID: 23085777.
      View in: PubMed
    56. Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1086-96. PMID: 22811350.
      View in: PubMed
    57. Singh V, Arora V, Alam MJ, Garey KW. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus. Antimicrob Agents Chemother. 2012 Aug; 56(8):4360-4. PMID: 22664967; PMCID: PMC3421605.
    58. Tran TT, Palmer HR, Weston J, Hirsch EB, Shah DN, Cottreau J, Tam VH, Garey KW. Evaluation of a daptomycin dose-optimization protocol. Am J Health Syst Pharm. 2012 Jun 1; 69(11):979-84. PMID: 22610031.
      View in: PubMed
    59. Mora AL, Salazar M, Pablo-Caeiro J, Frost CP, Yadav Y, DuPont HL, Garey KW. Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection. Am J Med Sci. 2012 Apr; 343(4):277-80. PMID: 21934595.
      View in: PubMed
    60. Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR, Garey KW. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother. 2012 Jun; 56(6):3239-43. PMID: 22411611; PMCID: PMC3370796.
    61. Cottreau J, Tucker A, Crutchley R, Garey KW. Crofelemer for the treatment of secretory diarrhea. Expert Rev Gastroenterol Hepatol. 2012 Feb; 6(1):17-23. PMID: 22149578.
      View in: PubMed
    62. Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs. Pharmacotherapy. 2012 Feb; 32(2):129-34. PMID: 22392421.
      View in: PubMed
    63. Palmer HR, Weston J, Gentry L, Salazar M, Putney K, Frost C, Tipton JA, Cottreau J, Tam VH, Garey KW. Improving patient care through implementation of an antimicrobial stewardship program. Am J Health Syst Pharm. 2011 Nov 15; 68(22):2170-4. PMID: 22058103.
      View in: PubMed
    64. Crutchley RD, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses. 2012 May; 28(5):454-9. PMID: 21878055.
      View in: PubMed
    65. Garey KW, Ghantoji SS, Shah DN, Habib M, Arora V, Jiang ZD, DuPont HL. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011 Dec; 66(12):2850-5. PMID: 21948965.
      View in: PubMed
    66. Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. Southeast Asian J Trop Med Public Health. 2011 Jul; 42(4):890-900. PMID: 22299471.
      View in: PubMed
    67. Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy. J Med Assoc Thai. 2011 Jul; 94(7):863-70. PMID: 21774295.
      View in: PubMed
    68. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, Garey KW. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2011 Sep; 66(9):2146-51. PMID: 21700622.
      View in: PubMed
    69. Arora V, Kachroo S, Ghantoji SS, Dupont HL, Garey KW. High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. J Hosp Infect. 2011 Sep; 79(1):23-6. PMID: 21700363.
      View in: PubMed
    70. Halton K, Arora V, Singh V, Ghantoji SS, Shah DN, Garey KW. Bacterial colonization on writing pens touched by healthcare professionals and hospitalized patients with and without cleaning the pen with alcohol-based hand sanitizing agent. Clin Microbiol Infect. 2011 Jun; 17(6):868-9. PMID: 21463395.
      View in: PubMed
    71. Sethi S, Garey KW, Arora V, Ghantoji S, Rowan P, Smolensky M, DuPont HL. Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection. J Hosp Infect. 2011 Feb; 77(2):172-3. PMID: 21190754.
      View in: PubMed
    72. Garey KW, Jiang ZD, Ghantoji S, Tam VH, Arora V, Dupont HL. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis. 2010 Dec 15; 51(12):1406-10. PMID: 21058913.
      View in: PubMed
    73. Bhagunde P, Chang KT, Singh R, Singh V, Garey KW, Nikolaou M, Tam VH. Mathematical modeling to characterize the inoculum effect. Antimicrob Agents Chemother. 2010 Nov; 54(11):4739-43. PMID: 20805390; PMCID: PMC2976129.
    74. Dupont HL, Garey KW. Clostridium difficile infection: an emerging epidemic with more questions than answers. Future Microbiol. 2010 Aug; 5(8):1153-6. PMID: 20722592.
      View in: PubMed
    75. Palmer HR, Cottreau JM, Garey KW, Hirsch EB, Musick WL, Tam VH, Yeh RF. Significant publications on infectious diseases pharmacotherapy in 2009. Am J Health Syst Pharm. 2010 Aug; 67(15):e34-42. PMID: 20651305.
      View in: PubMed
    76. Koo HL, Garey KW, Dupont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36. PMID: 20521993; PMCID: PMC3159574.
    77. Cottreau J, Baker SF, DuPont HL, Garey KW. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):747-60. PMID: 20586560.
      View in: PubMed
    78. Tam VH, Rogers CA, Chang KT, Weston JS, Caeiro JP, Garey KW. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother. 2010 Sep; 54(9):3717-22. PMID: 20585122; PMCID: PMC2935002.
    79. Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64. PMID: 20455684; PMCID: PMC3138198.
    80. Crutchley RD, Miller J, Garey KW. Crofelemer, a novel agent for treatment of secretory diarrhea. Ann Pharmacother. 2010 May; 44(5):878-84. PMID: 20388859.
      View in: PubMed
    81. Jiang ZD, DuPont HL, La Rocco M, Garey KW. In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas. J Clin Pathol. 2010 Apr; 63(4):355-8. PMID: 20354207.
      View in: PubMed
    82. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010 Apr; 74(4):309-18. PMID: 20153547.
      View in: PubMed
    83. Birtcher KK, Corbett SM, Pass SE, Coyle EA, Yeh RF, Tipton J, Garey KW. Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians. Am J Health Syst Pharm. 2010 Feb 1; 67(3):231-8. PMID: 20101067.
      View in: PubMed
    84. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, Weston JS, Caeiro JP, Garey KW. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010 Mar; 54(3):1160-4. PMID: 20086165; PMCID: PMC2826008.
    85. Salazar M, Baskin L, Garey KW, DuPont HL. Clostridium difficile-related death rates in Texas 1999-2005. J Infect. 2009 Nov; 59(5):303-7. PMID: 19735673.
      View in: PubMed
    86. Salazar M, Garey KW, Jiang ZD, Dao-Tran T, Dupont H. Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital. Pharm World Sci. 2009 Oct; 31(5):565-71. PMID: 19657721.
      View in: PubMed
    87. Yadav Y, Garey KW, Dao-Tran TK, Kaila V, Gbito KY, DuPont HL. Automated system to identify Clostridium difficile infection among hospitalised patients. J Hosp Infect. 2009 Aug; 72(4):337-41. PMID: 19596490.
      View in: PubMed
    88. Jiang ZD, Dupont HL, La Rocco M, Garey KW. WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas. Anaerobe. 2009 Feb 15. PMID: 19223017.
      View in: PubMed
    89. Tam VH, Chang KT, Schilling AN, LaRocco MT, Genty LO, Garey KW. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis. 2009 Mar; 63(3):279-85. PMID: 19135330.
      View in: PubMed
    90. Garey KW, Jiang ZD, Bellard A, Dupont HL. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study. J Clin Gastroenterol. 2009 Jan; 43(1):91-3. PMID: 18385603.
      View in: PubMed
    91. Garey KW, Vo QP, Larocco MT, Gentry LO, Tam VH. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia. J Chemother. 2008 Dec; 20(6):714-20. PMID: 19129069.
      View in: PubMed
    92. Yeh RF, Kuper KM, Coyle EA, Garey KW, Ikwuagwu JO, Maclayton DO, Mohr JF, Musick WL, Pass SE, Rios E, Tam VH. Significant publications on infectious diseases pharmacotherapy in 2007. Am J Health Syst Pharm. 2008 Nov 15; 65(22):e72-9. PMID: 18997127.
      View in: PubMed
    93. Garey KW, Vo QP, Lewis RE, Saengcharoen W, LaRocco MT, Tam VH. Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin. Diagn Microbiol Infect Dis. 2009 Jan; 63(1):81-6. PMID: 18990530.
      View in: PubMed
    94. Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008 Dec; 70(4):298-304. PMID: 18951661.
      View in: PubMed
    95. DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008 Oct; 21(5):500-7. PMID: 18725800.
      View in: PubMed
    96. Garey KW, Martorell MV, Vo QP, Tam VH. Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosa. J Chemother. 2008 Oct; 20(5):652-4. PMID: 19028631.
      View in: PubMed
    97. Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect. 2008 Oct; 70(2):142-7. PMID: 18723249.
      View in: PubMed
    98. Garey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL. Peripartum Clostridium difficile infection: case series and review of the literature. Am J Obstet Gynecol. 2008 Oct; 199(4):332-7. PMID: 18639213.
      View in: PubMed
    99. Garey KW, Amrutkar P, Dao-Tran TK, Frost CP, Chen H, Essien EJ, Gentry LO. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery. Pharmacotherapy. 2008 Jun; 28(6):699-706. PMID: 18503397.
      View in: PubMed
    100. Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother. 2008 Jun; 42(6):827-35. PMID: 18430792.
      View in: PubMed
    101. Tam VH, Gamez EA, Weston JS, Gerard LN, Larocco MT, Caeiro JP, Gentry LO, Garey KW. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Clin Infect Dis. 2008 Mar 15; 46(6):862-7. PMID: 18279040.
      View in: PubMed
    102. Lim TP, Garey KW, Tam VH. Pharmacokinetic/Pharmacodynamic antimicrobial individualization and optimization strategies. Curr Infect Dis Rep. 2008 Mar; 10(1):9-13. PMID: 18377809.
      View in: PubMed
    103. Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008 Feb; 52(2):446-51. PMID: 18025116; PMCID: PMC2224787.
    104. Garey KW, Pai MP, Suda KJ, Turpin RS, Rege MD, Mingo DE, Bearden DT. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf. 2007 Aug; 16(8):919-27. PMID: 17286303.
      View in: PubMed
    105. Jiang ZD, Garey KW, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M, DuPont HL. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):964-8. PMID: 17618838.
      View in: PubMed
    106. Tam VH, Chang KT, LaRocco MT, Schilling AN, McCauley SK, Poole K, Garey KW. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2007 Jul; 58(3):309-14. PMID: 17617302.
      View in: PubMed
    107. Chen H, Suda KJ, Turpin RS, Pai MP, Bearden DT, Garey KW. High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. Curr Med Res Opin. 2007 May; 23(5):1057-65. PMID: 17519072.
      View in: PubMed
    108. Loughlin SM, Mortazavi A, Garey KW, Rice GK, Birtcher KK. Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic. Pharmacotherapy. 2007 May; 27(5):729-33. PMID: 17461708.
      View in: PubMed
    109. Tam VH, Schilling AN, LaRocco MT, Gentry LO, Lolans K, Quinn JP, Garey KW. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. Clin Microbiol Infect. 2007 Apr; 13(4):413-8. PMID: 17359326.
      View in: PubMed
    110. Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. Int J Antimicrob Agents. 2007 May; 29(5):557-62. PMID: 17341444.
      View in: PubMed
    111. Itokazu GS, Schwartz DN, Garey KW, Rodvold KA, Danziger LH, Weinstein RA. Pharmacists' perceptions of the effectiveness of antimicrobial control programs. Am J Health Syst Pharm. 2006 Dec 15; 63(24):2504-8. PMID: 17158699.
      View in: PubMed
    112. Price MF, Dao-Tran T, Garey KW, Graham G, Gentry LO, Dhungana L, Dupont HL. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect. 2007 Jan; 65(1):42-6. PMID: 17145108.
      View in: PubMed
    113. Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW. Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection. 2006 Dec; 34(6):322-7. PMID: 17180586.
      View in: PubMed
    114. Pai MP, Turpin RS, Garey KW. Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia. Antimicrob Agents Chemother. 2007 Jan; 51(1):35-9. PMID: 17101684; PMCID: PMC1797664.
    115. Maclayton DO, Suda KJ, Coval KA, York CB, Garey KW. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther. 2006 Aug; 28(8):1208-16. PMID: 16982298.
      View in: PubMed
    116. Garey KW, Kumar N, Dao T, Tam VH, Gentry LO. Risk factors for postoperative chest wound infections due to gram-negative bacteria in cardiac surgery patients. J Chemother. 2006 Aug; 18(4):402-8. PMID: 17024796.
      View in: PubMed
    117. Garey KW, Dao T, Chen H, Amrutkar P, Kumar N, Reiter M, Gentry LO. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother. 2006 Sep; 58(3):645-50. PMID: 16807254.
      View in: PubMed
    118. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006 Jul 1; 43(1):25-31. PMID: 16758414.
      View in: PubMed
    119. Garey KW, Graham G, Gerard L, Dao T, Jiang ZD, Price M, Dupont HL. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother. 2006 Jun; 40(6):1030-4. PMID: 16684806.
      View in: PubMed
    120. Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses. 2006 May; 49(3):226-31. PMID: 16681815.
      View in: PubMed
    121. Jiang ZD, DuPont HL, Garey K, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006 May; 101(5):1112-6. PMID: 16573784.
      View in: PubMed
    122. Tam VH, Adams S, LaRocco MT, Gerard LN, Gentry LO, Garey KW. An integrated pharmacoeconomic approach to antimicrobial formulary decision-making. Am J Health Syst Pharm. 2006 Apr 15; 63(8):735-9. PMID: 16595813.
      View in: PubMed
    123. Kachroo S, Dao T, Zabaneh F, Reiter M, Larocco MT, Gentry LO, Garey KW. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization. Ann Pharmacother. 2006 Mar; 40(3):381-5. PMID: 16478809.
      View in: PubMed
    124. Suda KJ, Garey KW, Danziger LH. Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone. Pharm World Sci. 2005 Apr; 27(2):81-2. PMID: 15999916.
      View in: PubMed
    125. Gerard L, Garey KW, DuPont HL. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Ther. 2005 Apr; 3(2):201-11. PMID: 15918778.
      View in: PubMed
    126. Garey KW, Johle ML, Behrman K, Neuhauser MM. Economic consequences of unused medications in Houston, Texas. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1165-8. PMID: 15138296.
      View in: PubMed
    127. Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest. 2004 Jan; 125(1):22-6. PMID: 14718416.
      View in: PubMed
    128. Gotfried MH, Jung R, Messick CR, Rubinstein I, Garey KW, Rodvold KA, Danziger LH. Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study. Curr Ther Res Clin Exp. 2004 Jan; 65(1):1-12. PMID: 24936100; PMCID: PMC4052968.
    129. Neuhauser MM, Wiley D, Simpson L, Garey KW. Involvement of immunization-certified pharmacists with immunization activities. Ann Pharmacother. 2004 Feb; 38(2):226-31. PMID: 14742755.
      View in: PubMed
    130. Cannon JP, Fiscella R, Pattharachayakul S, Garey KW, De Alba F, Piscitelli S, Edward DP, Danziger LH. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci. 2003 May; 44(5):2112-7. PMID: 12714650.
      View in: PubMed
    131. Garey KW, Alwani A, Danziger LH, Rubinstein I. Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest. 2003 Jan; 123(1):261-5. PMID: 12527628.
      View in: PubMed
    132. Pendland SL, Neuhauser MM, Garey KW, Prause JL, Jung R. Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration. Diagn Microbiol Infect Dis. 2002 Sep; 44(1):59-61. PMID: 12376032.
      View in: PubMed
    133. Bearden DT, Neuhauser MM, Garey KW. Telithromycin: an oral ketolide for respiratory infections. Pharmacotherapy. 2001 Oct; 21(10):1204-22. PMID: 11601667.
      View in: PubMed
    134. Tornatore KM, Garey KW, Saigal N, Reed K, Murray B, Ingalls E, DiFrancesco R, Forrest A, Morse G, Venuto R. Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clin Transplant. 2001 Oct; 15(5):297-308. PMID: 11678955.
      View in: PubMed
    135. Cannon JP, Garey KW, Danziger LH. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations. Pharmacotherapy. 2001 Sep; 21(9):1107-14. PMID: 11560200.
      View in: PubMed
    136. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med. 2001 Sep 1; 164(5):731-7. PMID: 11549524.
      View in: PubMed
    137. Garey KW, Pendland SL, Huynh VT, Bunch TH, Jensen GM, Pursell KJ. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy. 2001 Jul; 21(7):855-60. PMID: 11444582.
      View in: PubMed
    138. Garey KW, Tesoro E, Muggia V, Pasquier O, Rodvold KA. Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitis. Pharmacotherapy. 2001 Jun; 21(6):748-50. PMID: 11401187.
      View in: PubMed
    139. Garey KW, Teichner P. Pharmacist intervention program for hospitalized patients with HIV infection. Am J Health Syst Pharm. 2000 Dec 15; 57(24):2283-4. PMID: 11146973.
      View in: PubMed
    140. Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH. Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest. 2000 Dec; 118(6):1826-7. PMID: 11115481.
      View in: PubMed
    141. Pendland SL, Diaz-Linares M, Garey KW, Woodward JG, Ryu S, Danziger LH. Bactericidal activity and postantibiotic effect of levofloxacin against anaerobes. Antimicrob Agents Chemother. 1999 Oct; 43(10):2547-9. PMID: 10508042; PMCID: PMC89518.
    142. Garey KW, Peloquin CA, Godo PG, Nafziger AN, Amsden GW. Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. Antimicrob Agents Chemother. 1999 May; 43(5):1152-5. PMID: 10223928; PMCID: PMC89125.
    143. Garey KW, Amsden GW. Intravenous azithromycin. Ann Pharmacother. 1999 Feb; 33(2):218-28. PMID: 10084418.
      View in: PubMed
    144. Garey KW, Amsden GW. Trovafloxacin: an overview. Pharmacotherapy. 1999 Jan; 19(1):21-34. PMID: 9917076.
      View in: PubMed
    145. Garey KW, Streetman DS, Rainish MC. Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother. 1998 Apr; 32(4):425-8. PMID: 9562137.
      View in: PubMed
    146. Garey KW, Amsden GW, Johns CA. Possible interaction between imipramine and butalbital. Pharmacotherapy. 1997 Sep-Oct; 17(5):1041-2. PMID: 9324197.
      View in: PubMed
    GAREY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _